Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.

Barbolina MV, Adley BP, Shea LD, Stack MS.

Cancer. 2008 Apr 1;112(7):1632-41. doi: 10.1002/cncr.23341.

2.

p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.

Pon YL, Zhou HY, Cheung AN, Ngan HY, Wong AS.

Cancer Res. 2008 Aug 15;68(16):6524-32. doi: 10.1158/0008-5472.CAN-07-6302.

3.

Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.

Zhang R, Shi H, Chen Z, Wu Q, Ren F, Huang H.

J Exp Clin Cancer Res. 2011 Sep 16;30:83. doi: 10.1186/1756-9966-30-83.

4.

Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.

Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B.

Cancer. 2005 Apr 15;103(8):1631-43.

5.

Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.

Horiuchi A, Hayashi T, Kikuchi N, Hayashi A, Fuseya C, Shiozawa T, Konishi I.

Int J Cancer. 2012 Oct 15;131(8):1755-67. doi: 10.1002/ijc.27448. Epub 2012 Mar 14.

6.

Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.

Iborra S, Hirschfeld M, Jaeger M, Zur Hausen A, Braicu I, Sehouli J, Gitsch G, Stickeler E.

Int J Gynecol Cancer. 2013 Jul;23(6):990-6. doi: 10.1097/IGC.0b013e31829783e3.

PMID:
23748175
7.

Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.

Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.

Int J Gynecol Cancer. 2009 Jul;19(5):860-6. doi: 10.1111/IGC.0b013e3181a8331f.

PMID:
19574774
8.

Overexpression of salusin-β is associated with poor prognosis in ovarian cancer.

Zhang Q, Chen WM, Zhang XX, Zhang HX, Wang HC, Zheng FY, Zhu FF.

Oncol Rep. 2017 Mar;37(3):1826-1832. doi: 10.3892/or.2017.5429. Epub 2017 Feb 7.

PMID:
28184918
9.

Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.

Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U, Bar-Shavit R.

Int J Cancer. 2005 Jan 20;113(3):372-8.

10.

Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.

Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H, Kudo T.

Anticancer Res. 2001 Jul-Aug;21(4B):2983-7.

PMID:
11712798
11.

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.

PMID:
12096084
12.

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.

Rao ZY, Cai MY, Yang GF, He LR, Mai SJ, Hua WF, Liao YJ, Deng HX, Chen YC, Guan XY, Zeng YX, Kung HF, Xie D.

Carcinogenesis. 2010 Sep;31(9):1576-83. doi: 10.1093/carcin/bgq150. Epub 2010 Jul 28.

PMID:
20668008
13.

Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.

Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr.

Cancer. 2008 Apr 1;112(7):1489-502. doi: 10.1002/cncr.23323.

14.

Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin.

Komiyama S, Kurahashi T, Ishikawa M, Tanaka K, Komiyama M, Mikami M, Udagawa Y.

Oncol Rep. 2011 Apr;25(4):1131-8. doi: 10.3892/or.2011.1151. Epub 2011 Jan 18.

PMID:
21249319
15.

Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.

Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F.

Int J Cancer. 2008 Jan 1;122(1):91-9.

16.

Interleukin-6 receptor enhances early colonization of the murine omentum by upregulation of a mannose family receptor, LY75, in ovarian tumor cells.

Giridhar PV, Funk HM, Gallo CA, Porollo A, Mercer CA, Plas DR, Drew AF.

Clin Exp Metastasis. 2011 Dec;28(8):887-97. doi: 10.1007/s10585-011-9420-x. Epub 2011 Sep 2.

PMID:
21887537
18.

Epigenetic and genetic alterations of p33ING1b in ovarian cancer.

Shen DH, Chan KY, Khoo US, Ngan HY, Xue WC, Chiu PM, Ip P, Cheung AN.

Carcinogenesis. 2005 Apr;26(4):855-63. Epub 2005 Jan 27.

PMID:
15677627
19.

Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.

Darb-Esfahani S, Wirtz RM, Sinn BV, Budczies J, Noske A, Weichert W, Faggad A, Scharff S, Sehouli J, Oskay-Ozcelik G, Zamagni C, De Iaco P, Martoni A, Dietel M, Denkert C.

Endocr Relat Cancer. 2009 Dec;16(4):1229-39. doi: 10.1677/ERC-08-0338. Epub 2009 Aug 12.

Supplemental Content

Support Center